By week 48 the 12 mg arm averaged 24.2 percent loss, the 8 mg arm landed near 22.8 percent, and even the 4 mg arm reached about 17.1 percent
To view or add a comment, sign in More Relevant Posts We are pleased to share our latest publication in Osteoarthritis and Cartilage Jourmal: A single intra-articular injection of JTA-004, a combination of human plasma, hyaluronic acid, and clonidine, versus placebo in symptomatic knee osteoarthritis: A Phase 3 trial Translating knowledge into clinical evidence is sometimes a long journeyespecially when results are not straightforward at first glance
Adverse-event tables capture what trial staff asked about or participants reported
Specially formulated for the safe reconstitution and long-term stability of lyophilized peptides
J Clin Invest 113(1):1418
Ultimately, the question of whether BPC 157 should be injected intramuscularly is a nuanced one, but the conclusion is refreshingly simple